Navigation

Publications

2012

Lysell J, Padyukov L, Kockum I, Nikamo P, Ståhle M.

Genetic Association with ERAP1 in Psoriasis Is Confined to Disease Onset after Puberty and Not Dependent on HLA-C*06.

J Invest Dermatol. 2012 Aug 30. doi: 10.1038/jid.2012.280. [Epub ahead of print]

Xu N, Zhang L, Meisgen F, Harada M, Heilborn J, Homey B, Grandér D, Ståhle M, Sonkoly E, Pivarcsi A.

MicroRNA-125b Down-regulates Matrix Metallopeptidase 13 and Inhibits Cutaneous Squamous Cell Carcinoma Cell Proliferation, Migration, and Invasion.

J Biol Chem. 2012 Aug 24;287(35):29899-908. Epub 2012 Jul 10.

Sääf A, Pivarcsi A, Winge MC, Wahlgren CF, Homey B, Nordenskjöld M, Tengvall-Linder M, Bradley M.

Characterization of EGFR and ErbB2 expression in atopic dermatitis patients.

Arch Dermatol Res. 2012 May 3. [Epub ahead of print]

Meisgen F, Xu N, Wei T, Janson PC, Obad S, Broom O, Nagy N, Kauppinen S, Kemény L, Ståhle M, Pivarcsi A, Sonkoly E.

MiR-21 is up-regulated in psoriasis and suppresses T cell apoptosis.

Exp Dermatol. 2012 Apr;21(4):312-4. doi: 10.1111/j.1600-0625.2012.01462.x.

Sonkoly E, Lovén J, Xu N, Meisgen F, Wei T, Brodin P, Jaks V, Kasper M, Shimokawa T, Harada M, Heilborn J, Hedblad M-A,Hippe A, Grandér D, Homey B, Zaphiropoulos PG, Arsenian-Henriksson M, Ståhle M and Pivarcsi A

MicroRNA-203 functions as a tumor suppressor in basal cell carcinoma

Oncogenesis (2012) 1, e3; doi:10.1038/oncsis.2012.3; published online 12 March 2012

Nikamo P, Ståhle M.

Cost-effective HLA-Cw06:02 typing in a Caucasian population.

Exp Dermatol. 2012 Mar;21(3):221-3. doi: 10.1111/j.1600-0625.2011.01423.x.

Girnita A, Zheng H, Grönberg A, Girnita L, Ståhle M.

Identification of the cathelicidin peptide LL-37 as agonist for the type I insulin-like growth factor receptor.

Oncogene. 2012 Jan 19;31(3):352-65. doi: 10.1038/onc.2011.239. Epub 2011 Jun 20.

Last modified by: Gunilla Ekstrand 2012-09-04